These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 17167418

  • 1. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
    Chai Q, Arndt JW, Dong M, Tepp WH, Johnson EA, Chapman ER, Stevens RC.
    Nature; 2006 Dec 21; 444(7122):1096-100. PubMed ID: 17167418
    [Abstract] [Full Text] [Related]

  • 2. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R, Rummel A, Binz T, Brunger AT.
    Nature; 2006 Dec 21; 444(7122):1092-5. PubMed ID: 17167421
    [Abstract] [Full Text] [Related]

  • 3. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.
    Willjes G, Mahrhold S, Strotmeier J, Eichner T, Rummel A, Binz T.
    Biochemistry; 2013 Jun 04; 52(22):3930-8. PubMed ID: 23647335
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
    Dong M, Tepp WH, Liu H, Johnson EA, Chapman ER.
    J Cell Biol; 2007 Dec 31; 179(7):1511-22. PubMed ID: 18158333
    [Abstract] [Full Text] [Related]

  • 5. Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.
    Berntsson RP, Peng L, Svensson LM, Dong M, Stenmark P.
    Structure; 2013 Sep 03; 21(9):1602-11. PubMed ID: 23932591
    [Abstract] [Full Text] [Related]

  • 6. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
    Peng L, Berntsson RP, Tepp WH, Pitkin RM, Johnson EA, Stenmark P, Dong M.
    J Cell Sci; 2012 Jul 01; 125(Pt 13):3233-42. PubMed ID: 22454523
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
    Stenmark P, Dong M, Dupuy J, Chapman ER, Stevens RC.
    J Mol Biol; 2010 Apr 16; 397(5):1287-97. PubMed ID: 20219474
    [Abstract] [Full Text] [Related]

  • 8. Structural biology: dangerous liaisons on neurons.
    Schiavo G.
    Nature; 2006 Dec 21; 444(7122):1019-20. PubMed ID: 17167419
    [No Abstract] [Full Text] [Related]

  • 9. Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity.
    Strotmeier J, Willjes G, Binz T, Rummel A.
    FEBS Lett; 2012 Feb 17; 586(4):310-3. PubMed ID: 22265973
    [Abstract] [Full Text] [Related]

  • 10. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.
    Rummel A, Eichner T, Weil T, Karnath T, Gutcaits A, Mahrhold S, Sandhoff K, Proia RL, Acharya KR, Bigalke H, Binz T.
    Proc Natl Acad Sci U S A; 2007 Jan 02; 104(1):359-64. PubMed ID: 17185412
    [Abstract] [Full Text] [Related]

  • 11. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW, Chai Q, Christian T, Stevens RC.
    Biochemistry; 2006 Mar 14; 45(10):3255-62. PubMed ID: 16519520
    [Abstract] [Full Text] [Related]

  • 12. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
    Strotmeier J, Lee K, Völker AK, Mahrhold S, Zong Y, Zeiser J, Zhou J, Pich A, Bigalke H, Binz T, Rummel A, Jin R.
    Biochem J; 2010 Oct 15; 431(2):207-16. PubMed ID: 20704566
    [Abstract] [Full Text] [Related]

  • 13. Synaptotagmin Binding to Botulinum Neurotoxins.
    Martínez-Carranza M, Blasco P, Gustafsson R, Dong M, Berntsson RP, Widmalm G, Stenmark P.
    Biochemistry; 2020 Feb 04; 59(4):491-498. PubMed ID: 31809018
    [Abstract] [Full Text] [Related]

  • 14. Structural analysis of botulinum neurotoxin type G receptor binding .
    Schmitt J, Karalewitz A, Benefield DA, Mushrush DJ, Pruitt RN, Spiller BW, Barbieri JT, Lacy DB.
    Biochemistry; 2010 Jun 29; 49(25):5200-5. PubMed ID: 20507178
    [Abstract] [Full Text] [Related]

  • 15. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.
    Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER.
    J Cell Biol; 2003 Sep 29; 162(7):1293-303. PubMed ID: 14504267
    [Abstract] [Full Text] [Related]

  • 16. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
    Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT.
    J Biol Chem; 2012 Nov 23; 287(48):40806-16. PubMed ID: 23027864
    [Abstract] [Full Text] [Related]

  • 17. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
    Rummel A, Mahrhold S, Bigalke H, Binz T.
    FEBS J; 2011 Dec 23; 278(23):4506-15. PubMed ID: 21624052
    [Abstract] [Full Text] [Related]

  • 18. Dominant antigenic peptides located at the heavy chain terminal of botulinum neurotoxin B contain receptor-binding sites for synaptotagmin II.
    Shi J, Bao S, Yin J, Cai K, Hou X, Xiao L, Tu W, Wang Q, Wang H.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):331-5. PubMed ID: 18639519
    [Abstract] [Full Text] [Related]

  • 19. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420
    [Abstract] [Full Text] [Related]

  • 20. Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.
    Flores A, Ramirez-Franco J, Desplantes R, Debreux K, Ferracci G, Wernert F, Blanchard MP, Maulet Y, Youssouf F, Sangiardi M, Iborra C, Popoff MR, Seagar M, Fantini J, Lévêque C, El Far O.
    Proc Natl Acad Sci U S A; 2019 Sep 03; 116(36):18098-18108. PubMed ID: 31431523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.